NARSAD
Welcome, guest
[login or register]
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Claudia Schmauss, M.D. (Independent Investigator 2004) of Columbia University, notes that attention deficits are prominent features of schizophrenia and are thought to result from abnormal neuronal activity in the prefrontal cortex (PFC), an anatomic structure critically involved in “top-down” conceptual cognitive processing. Although the mesocortical dopaminergic system
has been implicated in the control of these cognitive processes, the role of dopamine subtypes in attention is not fully understood. Using a mouse model, Dr. Schmauss studied the performance of mice lacking dopamine D2 and D3 receptors in a cognitive task that tests ability to acquire rules, maintain and shift attentional sets, and requires flexibility to respond to reversal conditions, and found that D2 mutants had significant deficits in rule learning. She will now test whether the extent of the neuronal activation in the mPFC in response to the attention-requiring test is modulated by D2 and D3 receptors and whether it is inversely correlated with the error rates by performing an assessment of the number of neurons that express task-induced FOS-immunoreactivity in the mPFC in 3 types of mice. She will also test whether the longer response latencies of D3 mutants are due to decreased reward expectation. She believes these studies will provide information into the different roles of D2 and D3 receptors, the main targets of anti-psychotics.

Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Independent Investigator application deadline: March 5, 2008

2008 Young Investigator, 2008 Distinguished Investigator and 2008 Staglin Grantees Announced: March, 2008

2008 Distinguished Investigator Earliest Start Date: May 1, 2008

2009 Distinguished Investigator Award application deadline: May 15, 2008

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award application deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Award Earliest Start Date: September 15, 2008

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009





NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us